Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange Other stock markets 07:30:00 05/08/2026 BST			5-day change	1st Jan Change
2,140.50 ^JPY	-5.16%		-11.33%	-11.95%

06-30	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI
06-22	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	375,465	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-18.27%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	375,465	375,465	375,465
Change	-	11%	26.5%	2.46%	24.61%	24.35%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	16.6x	14.1x	14.7x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.79x	0.75x	0.75x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.8x	-3.55x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.12x	0.12x	0.11x
EV / Revenue	0x	0x	0x	0x	0x	0.12x	0.12x	0.11x
EV / EBITDA	0x	0x	0x	0x	0x	7.6x	7.37x	7.16x
EV / EBIT	0x	0x	0x	0x	0x	10.8x	10x	9.88x
EV / FCF	0x	-0x	0x	-0x	0x	17.1x	22.9x	28.9x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.86%	4.36%	3.46%
Dividend per Share ²	54	57	70	63	68	71	79	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.15%	3.5%	3.77%
EPS ²	153.6	127.4	154.1	147.5	229.6	135.6	159.7	153.1
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	52.3%	49.5%	55.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,169,172	3,257,429	3,303,325
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	49,403	50,936	52,464
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,703	37,469	38,019
Net income ¹	32,182	25,786	29,558	27,389	41,746	24,286	27,651	27,336
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,257.00	2,257.00	2,257.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,410	-	-
Announcement Date	16/05/22	15/05/23	14/05/24	15/05/25	15/05/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALFRESA HOLDINGS CORPORATION	16.64x	-	-	3.15%	2.51B
ABBOTT LABORATORIES	30.2x	4.11x	15.95x	2.44%	182B
MEDTRONIC PLC	19.53x	3.41x	11.99x	3.45%	110B
CENCORA, INC.	17.04x	0.19x	12.04x	0.77%	59.59B
HOYA CORPORATION	31.84x	7.93x	20.18x	1.25%	55.04B
BECTON, DICKINSON AND COMPANY	37.04x	3.28x	11.19x	2.31%	46.87B
MEDLINE INC.	40.3x	1.45x	12.76x	0.2%	35.55B
DEXCOM, INC.	35.05x	6.15x	19.32x	-.--%	32.81B
WEST PHARMACEUTICAL SERVICES, INC.	40.67x	7.12x	25.57x	0.26%	24.54B
STERIS PLC	25.64x	3.76x	13.17x	1.12%	22.69B
Average	29.39x	4.16x	15.80x	1.49%	57.24B
Weighted average by Cap.	28.60x	3.93x	15.09x	1.91%